Maju Mathew Koola, MD
Department of Psychiatry and Behavioral Sciences, George Washington University School of Medicine and Health Sciences, Washington, DC
- 13Articles
- 67.1KReads1
- 2014–2026Active
- 46Collaborators
- 56Citations2
About
Maju Mathew Koola, MD, is affiliated with the Department of Psychiatry and Behavioral Sciences at George Washington University School of Medicine and Health Sciences. With publications spanning 2014 to 2026, Koola has contributed extensively to topics including addiction, neurology, depression, Alzheimer disease, COVID-19, delirium, electroconvulsive therapy, and stroke. The author’s work addresses clinical issues such as opioid use disorder, benzodiazepine-resistant catatonia, cognitive impairments related to neurological and psychiatric disorders, and treatment-resistant depression. Frequent collaborators include Sajoy P. Varghese, Erica J. Duncan, and Heshan Wijegunaratne.
Publications
Galantamine-Memantine for Cognitive Impairments
March 1, 2018
Association of Ophthalmologic Disorders and Depression in the Elderly: A Review of the Literature
August 20, 2015
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.